HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

asperthecin

from Aspergillus nidulans; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Anthracenes: 12
        Anthrones: 12
        Anthraquinones: 788
        asperthecin: 1
- Quinones: 434
  - Anthraquinones: 788
    - asperthecin: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Anthracenes: 12
    - Anthrones: 12
      - Anthraquinones: 788
        asperthecin: 1

Experts

1.	Chiang, Yi-Ming: 1 article (01/2014)
2.	Entwistle, Ruth: 1 article (01/2014)
3.	Gamblin, T Chris: 1 article (01/2014)
4.	Oakley, Berl R: 1 article (01/2014)
5.	Paranjape, Smita R: 1 article (01/2014)
6.	Sanchez, James F: 1 article (01/2014)
7.	Wang, Clay C C: 1 article (01/2014)

Related Diseases

1.	Tauopathies 01/01/2014 - "Together, our data demonstrates the potential of 2,ω-dihydroxyemodin, asperthecin, and asperbenzaldehyde as lead compounds for further development as therapeutics to inhibit tau aggregation in Alzheimer's disease and neurodegenerative tauopathies."
2.	Alzheimer Disease (Alzheimer's Disease) 01/01/2014 - "Together, our data demonstrates the potential of 2,ω-dihydroxyemodin, asperthecin, and asperbenzaldehyde as lead compounds for further development as therapeutics to inhibit tau aggregation in Alzheimer's disease and neurodegenerative tauopathies."

Related Drugs and Biologics

1.	asperbenzaldehyde

Related Therapies and Procedures

1.	Therapeutics